New Enterprise Associates 16, L.P.

13F Holdings History for Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Symbol: MRKR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 1.67M shares
Security Ownership: 9.9%

New Enterprise Associates 16, L.P. ownership in Marker Therapeutics, Inc. Common Stock, par value $0.001 per share (MRKR)

2025-11-17 - New Enterprise Associates 16, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.67M shares of Marker Therapeutics, Inc. Common Stock, par value $0.001 per share (MRKR). This represents 9.9% percent ownership of the company. In their previous filing dated 2025-08-18, New Enterprise Associates 16, L.P. had reported owning 1.63M shares, indicating an increase of 2.73% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
New Enterprise Associates 16, L.P.	9.9%	-20.8%	$1.7M	1.67M	+44,403	+2.73%	$1.02	13D/A	11/13/2025	17 Nov 2025 16:22:54
New Enterprise Associates 16, L.P.	12.6%	-17.3%	$1.53M	1.63M			$0.94	13D/A	8/14/2025	18 Aug 2025 17:34:11
New Enterprise Associates 16, L.P.	15.2%		$1.67M	1.63M			$1.03	13D/A	12/19/2024	23 Dec 2024 16:30:16